7832430|t|Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).
7832430|a|The current research has demonstrated that MPP+ can induce lipid peroxidation in the nigrostriatal system of rat in vivo. Antioxidant agent U-78517F and .OH scavenger DMSO may protect against MPP+ toxicity through the inhibition of .OH radical-mediated oxidative injury in the substantia nigra. These findings indicate that the cytotoxic hydroxyl radical generated from dopamine oxidation in the iron-rich basal ganglia may contribute to the mechanism underlying the selective A9 melanized nigral degeneration in MPTP-Parkinsonism and possibly in idiopathic Parkinson's disease. In addition, the present studies also clearly demonstrate that deprenyl can substantially protect dopaminergic neurons against MPP+ toxicity in the substantia nigra zona compacta in vivo. The neuroprotective effect provided by deprenyl may not be the consequence of its inhibition of MAO-B activity or prevention of the uptake of MPP+ by dopaminergic neurons. A unique antioxidant property of deprenyl by suppressing .OH formation and associated oxidative injury induced by MPP+ may contribute to the apparent neuroprotective action. In perspective, this putative antioxidant effect of deprenyl may provide another mechanism to its overt neuroprotective effects against oxygen radical-mediated oxidative injury in some neurotoxic chemicals, such as 6-OHDA and DSP-4, and probably in Alzheimer's disease and senescent changes. Finally, based on the present data, a possible neuroprotective therapeutic window of deprenyl in the treatment of early Parkinson's disease has been proposed. It is suggested that deprenyl should be introduced as early as possible in de novo Parkinsonian patients to achieve its full neuroprotective effect on nigral degeneration. Moreover, a combination of early detection of individuals at risk of developing Parkinson's disease and early intervention of deprenyl and/or other centrally active antioxidants to these patients may provide a new preventive therapeutic strategy in the future, in addition to the current conventional levodopa treatment of Parkinson's disease.
7832430	68	76	toxicity	Disease	MESH:D064420
7832430	80	88	deprenyl	Chemical	MESH:D012642
7832430	90	100	selegiline	Chemical	MESH:D012642
7832430	162	167	lipid	Chemical	MESH:D008055
7832430	212	215	rat	Species	10116
7832430	243	251	U-78517F	Chemical	MESH:C066382
7832430	270	274	DMSO	Chemical	MESH:D004121
7832430	300	308	toxicity	Disease	MESH:D064420
7832430	431	440	cytotoxic	Disease	MESH:D064420
7832430	441	457	hydroxyl radical	Chemical	MESH:D017665
7832430	473	481	dopamine	Chemical	MESH:D004298
7832430	499	503	iron	Chemical	MESH:D007501
7832430	580	582	A9	CellLine	CVCL:RG56
7832430	583	612	melanized nigral degeneration	Disease	MESH:D008548
7832430	616	620	MPTP	Chemical	MESH:D015632
7832430	621	633	Parkinsonism	Disease	MESH:D010302
7832430	650	680	idiopathic Parkinson's disease	Disease	MESH:D010300
7832430	745	753	deprenyl	Chemical	MESH:D012642
7832430	814	822	toxicity	Disease	MESH:D064420
7832430	909	917	deprenyl	Chemical	MESH:D012642
7832430	966	971	MAO-B	Gene	25750
7832430	1075	1083	deprenyl	Chemical	MESH:D012642
7832430	1268	1276	deprenyl	Chemical	MESH:D012642
7832430	1352	1366	oxygen radical	Chemical	MESH:D017382
7832430	1401	1411	neurotoxic	Disease	MESH:D020258
7832430	1431	1437	6-OHDA	Chemical	MESH:D016627
7832430	1442	1447	DSP-4	Chemical	MESH:C012102
7832430	1465	1484	Alzheimer's disease	Disease	MESH:D000544
7832430	1593	1601	deprenyl	Chemical	MESH:D012642
7832430	1628	1647	Parkinson's disease	Disease	MESH:D010300
7832430	1688	1696	deprenyl	Chemical	MESH:D012642
7832430	1750	1762	Parkinsonian	Disease	MESH:D010300
7832430	1763	1771	patients	Species	9606
7832430	1818	1837	nigral degeneration	Disease	MESH:D009410
7832430	1919	1938	Parkinson's disease	Disease	MESH:D010300
7832430	1965	1973	deprenyl	Chemical	MESH:D012642
7832430	2026	2034	patients	Species	9606
7832430	2140	2148	levodopa	Chemical	MESH:D007980
7832430	2162	2181	Parkinson's disease	Disease	MESH:D010300
7832430	Positive_Correlation	MESH:D015632	MESH:D017665
7832430	Positive_Correlation	MESH:D015632	MESH:D010302
7832430	Association	MESH:D004298	MESH:D007501
7832430	Association	MESH:D016627	MESH:D017382
7832430	Association	MESH:D017665	MESH:D010300
7832430	Association	MESH:D007501	MESH:D008548
7832430	Negative_Correlation	MESH:C066382	MESH:D064420
7832430	Association	MESH:D007501	MESH:D017665
7832430	Positive_Correlation	MESH:D017665	MESH:D008548
7832430	Association	MESH:C012102	MESH:D017382
7832430	Association	MESH:D017382	MESH:D000544
7832430	Negative_Correlation	MESH:D012642	MESH:D010300
7832430	Association	MESH:D004298	MESH:D010300
7832430	Association	MESH:D004298	MESH:D010302
7832430	Association	MESH:D004298	MESH:D017665
7832430	Negative_Correlation	MESH:D012642	MESH:D000544
7832430	Association	MESH:D004298	MESH:D008548
7832430	Positive_Correlation	MESH:D017665	MESH:D010302
7832430	Negative_Correlation	MESH:D012642	MESH:D064420
7832430	Negative_Correlation	MESH:D004121	MESH:D064420
7832430	Association	MESH:C012102	MESH:D012642
7832430	Negative_Correlation	MESH:D012642	MESH:D009410
7832430	Association	MESH:D012642	MESH:D017382
7832430	Association	MESH:D012642	MESH:D016627
7832430	Negative_Correlation	MESH:D007980	MESH:D010300
7832430	Association	MESH:D017382	MESH:D020258
7832430	Positive_Correlation	MESH:D015632	MESH:D008548

